These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2211702

  • 21. Design and synthesis of peptide inhibitors of blood coagulations.
    Bajusz S, Széll E, Barabás E, Bagdy D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):16-21. PubMed ID: 6177598
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
    De Nanteuil G, Gloanec P, Lila C, Portevin B, Boudon A, Rupin A, Verbeuren TJ.
    Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
    Leblond L, Grouix B, Boudreau C, Yang Q, Siddiqui MA, Winocour PD.
    Thromb Res; 2000 Nov 01; 100(3):195-209. PubMed ID: 11108907
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
    Kettner C, Shaw E.
    Biochemistry; 1978 Oct 31; 17(22):4778-84. PubMed ID: 728386
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E, Elgendy S, Goodwin CA, Green D, Scully MF, Kakkar VV, Freyssinet JM, Dodson G, Deadman JJ.
    Biochemistry; 1998 Oct 13; 37(41):14420-7. PubMed ID: 9772168
    [Abstract] [Full Text] [Related]

  • 33. Analysis of the thrombin inhibitor DuP 714 by an enzyme-linked immunosorbent assay.
    Mitchell TJ, Knabb RM, Christ DD, Farmer AR, Reilly TM.
    Blood Coagul Fibrinolysis; 1994 Aug 13; 5(4):517-21. PubMed ID: 7841307
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J, Powers JC.
    Biochemistry; 1991 Jan 15; 30(2):485-93. PubMed ID: 1988040
    [Abstract] [Full Text] [Related]

  • 36. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M, Peters CA, Visser A, Grootenhuis PD, van Nispen JW, Ottenheijm HC.
    Bioorg Med Chem; 1995 Aug 15; 3(8):1099-114. PubMed ID: 7582983
    [Abstract] [Full Text] [Related]

  • 37. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals, new orally active stable analogues of D-Phe-Pro-Arg-H.
    Bajusz S, Barabas E, Fauszt I, Feher A, Horvath G, Juhasz A, Szabo GA, Szell E.
    Semin Thromb Hemost; 1996 Aug 15; 22(3):243-6. PubMed ID: 8836008
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structure/function aspects of neutral P1 residue peptide inhibitors of thrombin.
    Deadman J, Claeson G, Scully MF.
    J Enzyme Inhib; 1995 Aug 15; 9(1):29-41. PubMed ID: 8568564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.